Found 9 matching trials
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer PHASE2 This phase II trial compares the effect of giving cabozantinib with or with...
Show More Location
Mayo Clinic Hospital in Arizona
Learn More & Join Trial
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma PHASE2 Tthe primary objective of this study is to compare blinded Independent Radi...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors PHASE1 Many tumor cells, in contrast to normal cells, have been shown to require t...
Show More Location
UCSF Helen Diller Family Comprehensive Cancer Center
Learn More & Join Trial
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain PHASE1 The purpose of this study is to find out whether the combination of cabozan...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Learn More & Join Trial
Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients PHASE2 Among patients with renal cell carcinoma (RCC), 2.7 to 4.7 % of patients ar...
Show More Location
Centre Hospitalier Universitaire de Besançon
Learn More & Join Trial
A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment PHASE3 This is a Phase III, multicenter, randomized, open-label study designed to ...
Show More Location
University of Arizona
Learn More & Join Trial
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma PHASE1 This is a Phase 1b/2 study of AVB-S6-500 designed to evaluate the safety an...
Show More Location
University of Maryland Greenebaum Comprehensive Cancer Center
Learn More & Join Trial
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma PHASE1 Immunotherapy has gained a significant amount of attention recently, but it...
Show More Location
O'Neal Comprehensive Cancer Center at UAB
Learn More & Join Trial
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC) PHASE2 The goal of this clinical trial is to learn about the effects of a higher d...
Show More Location
UT Southwestern Medical Center
Learn More & Join Trial